Immunovant Q2 2026 Earnings Preview

* Immunovant (IMVT [https://seekingalpha.com/symbol/IMVT]) is scheduled to announce Q2 earnings results on Friday, November 7th, after market close.
* The consensus EPS Estimate is -$0.73 [https://seekingalpha.com/symbol/IMVT/earnings/estimates] (+1.4% Y/Y) and the consensus Revenue Estimate is $0M.
* Over the last 3 months, EPS estimates have seen 3 upward revisions [https://seekingalpha.com/symbol/IMVT/earnings/revisions] and 6 downward.

MORE ON IMMUNOVANT

* Immunovant: Takeover Buzz, IMVT-1402 Promise, And Why I'm Staying Neutral [https://seekingalpha.com/article/4836470-immunovant-takeover-buzz-imvt-1402-promise-and-why-im-staying-neutral]
* Seeking Alpha’s Quant Rating on Immunovant [https://seekingalpha.com/symbol/IMVT/ratings/quant-ratings]
* Historical earnings data for Immunovant [https://seekingalpha.com/symbol/IMVT/earnings]
* Financial information for Immunovant [https://seekingalpha.com/symbol/IMVT/income-statement]